A new generic formulation of pyridostigmine bromide — a muscle-strengthening medication sold under the brand name Mestinon — is now available for people with myasthenia gravis (MG) in the U.S. [read more in Myasthenia Gravis News]
Monthly Archives: April 2024
Read study results on patient perceptions of disease burden and treatment of myasthenia gravis based on sentiment analysis of digital conversations
Scientific Reports shares results from a study that looks at disease burden. Public domain digital conversations about MG were analyzed to describe mindsets and sentiments about the disease, its burden, and its treatments among men and women with MG and, more specifically, those treated with steroids and those receiving IVIg.
